about
Citral alleviates an accelerated and severe lupus nephritis model by inhibiting the activation signal of NLRP3 inflammasome and enhancing Nrf2 activationA RG-II type polysaccharide purified from Aconitum coreanum alleviates lipopolysaccharide-induced inflammation by inhibiting the NF-κB signal pathwayHeat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosusAbnormal production of pro- and anti-inflammatory cytokines by lupus monocytes in response to apoptotic cells.Effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in Indian SLE patients.Lupus nephritis: an overview of recent findings.Novel treatments for systemic lupus erythematosus.Lessons for lupus from tumour necrosis factor blockade.Up-regulation of activating transcription factor-5 suppresses SAP expression to activate T cells in hemophagocytic syndrome associated with Epstein-Barr virus infection and immune disorders.Biomarkers of lupus nephritis determined by serial urine proteomicsKallikrein transduced mesenchymal stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation and oxidative stressTRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects.Cytokines and their receptors as biomarkers of systemic lupus erythematosus.Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis.Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling.Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE).Anticytokine therapy in systemic lupus erythematosus.Proteome analysis of biological fluids from autoimmune-rheumatological disorders.Progress with the use of monoclonal antibodies for the treatment of systemic lupus erythematosus.(5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/lpr mice by preventing infiltration of immune cells.Pleiotropic signaling evoked by tumor necrosis factor in podocytes.Short-term add-on tocilizumab and intravenous cyclophosphamide exhibited a remission-inducing effect in a patient with systemic lupus erythematosus with refractory multiorgan involvements including massive pericarditis and glomerulonephritis.Interleukin-6 receptor alpha blockade improves skin lesions in a murine model of systemic lupus erythematosus.A protective role of Mer receptor tyrosine kinase in nephrotoxic serum-induced nephritis.Jak/STAT signaling is involved in the inflammatory infiltration of the kidneys in MRL/lpr mice.Mycophenolate mofetil alleviates lupus nephritis through urokinase receptor signaling in a mice model.Up-regulated renal expression of TNF-alpha signalling adapter proteins in lupus glomerulonephritis.Soy isoflavones supplementation alleviates disease severity in autoimmune-prone MRL-lpr/lpr mice.Beneficial effect of Eucommia polysaccharides on systemic lupus erythematosus-like syndrome induced by Campylobacter jejuni in BALB/c mice.Gene expression of cytokines (TNF-α, IFN-γ), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus.Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients.Increased expression and secretion of interleukin-6 in human parvovirus B19 non-structural protein (NS1) transfected COS-7 epithelial cells.Interleukin-6 promotes systemic lupus erythematosus progression with Treg suppression approach in a murine systemic lupus erythematosus model.Hypertension and impaired vascular function in a female mouse model of systemic lupus erythematosus.
P2860
Q28394337-E7127994-71AD-4873-B4C7-6AF2F116F2ECQ28539700-3EBBB52E-51E4-4D52-BEF6-AFA7163729F9Q33577386-56A98E1D-23C7-475A-8019-09CC7D5CDE9EQ33851587-07BAA811-A07A-467D-BD36-8AE00DB80A59Q34754611-5A3D2FE6-B34A-45AB-A2DD-D16CAAB3382EQ35867038-C14C1629-D5C9-42CA-BED7-D3FB446F6624Q36059553-BC54C39A-B99A-473C-ADF9-EE1DB6C9D718Q36677012-51F5BAC4-449B-4DA2-A5BF-047D56EDCEAFQ36943080-01588376-BAC8-47FA-BCD5-D2ECE6AD05CEQ37038307-5CAF86A7-5A1F-40FD-ADCD-9072599CC4AEQ37039091-0EEB03BB-FC3D-4663-8631-B980252D657EQ37072767-D5922283-DF14-46D4-A094-72CCA9E4D14FQ37118987-EF587390-F7CE-427D-88B5-EAFBA3D0A9AFQ37129534-F12AA03C-0F4E-4BCD-8625-3EDA09A98E5DQ37453484-EFF61B9F-9B35-4294-942A-156FF899A5AAQ37709460-320D6FA6-DF97-46B9-B4F6-93C42E2D74C3Q37800306-8705582D-62FF-4832-9938-ADF2971D600AQ37830007-3CEE23AF-A6BE-4353-8573-10DA43DA9992Q38389307-0C06EF9F-21E1-485B-8494-0EB81054D95BQ38720673-6AF33755-F45F-4762-A522-C8F717ED9382Q38870270-3060A021-B67B-44A9-B67A-D43C60656353Q41641721-EE153940-6085-4F63-AD16-1A6EA3456E0AQ41908236-266D775E-CD80-41D6-A8E3-949ED6FCFEF9Q42734350-E74B8AC3-6D00-4C84-8456-84D4CEDD38DAQ43054630-E0087296-4753-490C-B1E2-C6F8361F70FFQ44766216-7665997D-D7C7-4BA7-9229-D063DFA5DA1DQ46158716-65AB733B-8F28-4CC5-B881-061215307D95Q46404853-C3DEB594-2058-473D-AF3E-9F148040A781Q47363813-89434B35-E788-4265-A38F-0F81C9267A96Q47422803-A3CD1BFE-B391-41B9-996E-08669A706B1FQ49884213-3F78D067-6FDF-4BD3-BD74-53E99BA472FEQ50736394-DF979EDF-77A5-4A48-B59E-268FDF88AF98Q51134392-42C83BAE-691B-45E4-9ACC-70CFB5EA1C6AQ51786420-0A6B450E-E49C-4711-95BB-DDC5B5CAF3F7
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cytokine expression in lupus kidneys.
@ast
Cytokine expression in lupus kidneys.
@en
type
label
Cytokine expression in lupus kidneys.
@ast
Cytokine expression in lupus kidneys.
@en
prefLabel
Cytokine expression in lupus kidneys.
@ast
Cytokine expression in lupus kidneys.
@en
P1433
P1476
Cytokine expression in lupus kidneys.
@en
P2093
P356
10.1191/0961203305LU2053OA
P577
2005-01-01T00:00:00Z